Bank of Nova Scotia
AMGN icon

Bank of Nova Scotia’s Amgen AMGN Stock Holding History

Bank of Nova Scotia’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111M Sell
314,227
-58,745
-16% -$20.9M 0.19% 96
2025
Q4 		$122M Buy
372,972
+205,363
+123% +$65.1M 0.18% 96
2025
Q3 		$47.3M Buy
167,609
+60,794
+57% +$17.6M 0.08% 178
2025
Q2 		$29.8M Buy
106,815
+24,093
+29% +$6.83M 0.06% 204
2025
Q1 		$25.8M Sell
82,722
-381,790
-82% -$113M 0.06% 222
2024
Q4 		$121M Buy
464,512
+311,604
+204% +$92.5M 0.21% 81
2024
Q3 		$49.3M Buy
152,908
+2,936
+2% +$960K 0.1% 141
2024
Q2 		$46.9M Buy
149,972
+56,268
+60% +$16.5M 0.09% 161
2024
Q1 		$26.7M Sell
93,704
-220,936
-70% -$64.6M 0.05% 218
2023
Q4 		$90.6M Buy
314,640
+260,012
+476% +$70.8M 0.17% 107
2023
Q3 		$14.7M Buy
54,628
+5,609
+11% +$1.4M 0.04% 267
2023
Q2 		$10.9M Buy
49,019
+1,799
+4% +$417K 0.03% 275
2023
Q1 		$11.4M Sell
47,220
-8,171
-15% -$2.01M 0.03% 258
2022
Q4 		$14.5M Buy
55,391
+1,887
+4% +$506K 0.04% 290
2022
Q3 		$12.1M Sell
53,504
-123
-0.2% -$29.8K 0.04% 277
2022
Q2 		$13M Sell
53,627
-21,899
-29% -$5.37M 0.03% 337
2022
Q1 		$18.3M Sell
75,526
-488,051
-87% -$112M 0.03% 348
2021
Q4 		$127M Buy
563,577
+458,714
+437% +$96.8M 0.18% 125
2021
Q3 		$22.3M Buy
104,863
+9,457
+10% +$2.18M 0.04% 337
2021
Q2 		$23.3M Sell
95,406
-53,060
-36% -$13.1M 0.04% 296
2021
Q1 		$36.9M Sell
148,466
-26,854
-15% -$6.41M 0.07% 212
2020
Q4 		$40.3M Buy
175,320
+24,287
+16% +$5.6M 0.09% 203
2020
Q3 		$38.4M Buy
+151,033
New +$37.4M 0.1% 172
2020
Q2 		– Sell
-526,248
Closed -$107M – 915
2020
Q1 		$107M Buy
526,248
+284,381
+118% +$62.1M 0.37% 66
2019
Q4 		$58.3M Sell
241,867
-25,148
-9% -$5.54M 0.14% 155
2019
Q3 		$51.7M Buy
267,015
+62,590
+31% +$12M 0.15% 133
2019
Q2 		$35.9M Sell
204,425
-62,453
-23% -$11.2M 0.15% 141
2019
Q1 		$50.5M Sell
266,878
-35,217
-12% -$6.73M 0.2% 116
2018
Q4 		$58.8M Buy
302,095
+115,536
+62% +$22.5M 0.28% 87
2018
Q3 		$38.7M Sell
186,559
-246,891
-57% -$48.7M 0.17% 116
2018
Q2 		$80M Buy
433,450
+303,743
+234% +$53.7M 0.44% 50
2018
Q1 		$22.1M Sell
129,707
-20,954
-14% -$3.85M 0.11% 173
2017
Q4 		$26.2M Sell
150,661
-28,961
-16% -$5.13M 0.12% 170
2017
Q3 		$33.5M Buy
179,622
+11,285
+7% +$2M 0.2% 116
2017
Q2 		$29M Sell
168,337
-433,525
-72% -$70.5M 0.15% 131
2017
Q1 		$98.7M Buy
601,862
+484,868
+414% +$80.6M 0.42% 42
2016
Q4 		$17.1M Buy
116,994
+29,116
+33% +$4.38M 0.09% 153
2016
Q3 		$14.7M Sell
87,878
-45,256
-34% -$7.65M 0.08% 126
2016
Q2 		$20.3M Buy
133,134
+118,950
+839% +$18.5M 0.12% 96
2016
Q1 		$2.13M Sell
14,184
-122,900
-90% -$18.3M 0.01% 293
2015
Q4 		$22.3M Buy
137,084
+122,964
+871% +$19.3M 0.11% 111
2015
Q3 		$1.95M Sell
14,120
-1,200
-8% -$189K 0.01% 266
2015
Q2 		$2.36M Buy
15,320
+2,367
+18% +$379K 0.01% 217
2015
Q1 		$2.07M Sell
12,953
-80,026
-86% -$12.6M 0.01% 228
2014
Q4 		$14.8M Buy
92,979
+80,419
+640% +$12.5M 0.06% 132
2014
Q3 		$1.76M Buy
12,560
+722
+6% +$94.3K 0.01% 237
2014
Q2 		$1.4M Sell
11,838
-1,000,496
-99% -$116M 0.01% 256
2014
Q1 		$124M Buy
1,012,334
+907,028
+861% +$110M 0.51% 28
2013
Q4 		$12M Buy
105,306
+95,308
+953% +$10.8M 0.05% 152
2013
Q3 		$1.12M Sell
9,998
-2,084
-17% -$226K 0.01% 259
2013
Q2 		$1.19M Buy
+12,082
New +$1.25M 0.01% 227

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of Nova Scotia's AMGN Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Amgen (AMGN) stake by 16% in Q1 2026, selling an estimated $20.9M and leaving 314,227 shares worth $111M. The position accounts for 0.19% of the portfolio, ranked #96.

Bank of Nova Scotia first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $127M in Q4 2021. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bank of Nova Scotia held 314,227 shares of Amgen worth $111M as of Q1 2026.
  • Bank of Nova Scotia sold 58,745 Amgen shares in Q1 2026, an estimated $20.9M.
  • Amgen made up 0.19% of Bank of Nova Scotia's portfolio in Q1 2026, its #96 holding.
  • Bank of Nova Scotia first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Bank of Nova Scotia's Amgen position peaked at $127M in Q4 2021.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.